 | Zacks: Analysts Expect DelMar Pharmaceuticals Inc (NASDAQ:DMPI) Will Post Earnings of -$0.05 Per Share
www.americanbankingnews.com - May 19 at 4:20 AM |
 | DMPI DelMar Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - May 15 at 6:38 PM |
| DelMar Pharmaceuticals (NASDAQ:DMPI) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - May 14 at 6:50 PM |
| DelMar Pharmaceuticals (NASDAQ:DMPI) Receives Buy Rating from Maxim Group
www.americanbankingnews.com - May 14 at 4:23 PM |
 | DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates
finance.yahoo.com - May 13 at 8:31 AM |
| Is DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) A Volatile Stock?
finance.yahoo.com - May 10 at 5:06 PM |
 | BRIEF-DelMar Pharmaceuticals Provides Enrollment Update In Phase 2 Clinical Trial Of Val-083 For Adjuvant Treatment Of Brain Tumors
www.reuters.com - May 5 at 4:00 PM |
| DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors
finance.yahoo.com - May 5 at 4:00 PM |
| DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension
finance.yahoo.com - March 26 at 8:27 AM |
| BRIEF-DelMar Pharmaceuticals Reports Over 50% Enrollment In Phase 2 Clinical Trial Of VAL-083 For Adjuvant Treatment Of Brain Tumors
www.reuters.com - March 5 at 10:36 AM |
|
| DelMar Pharmaceuticals [Nasdaq:DMPI] Reports Over 50% Enrollment in Phase 2 Clinical Trial of VAL-083 For Adjuvant Treatment of Brain Tumors
finance.yahoo.com - March 4 at 12:31 PM |
 | BRIEF-Delmar Pharma Enrolls Final Patient In Phase 2 Clinical Trial Of Val-083 For First-Line Treatment Of Brain Tumors
www.msn.com - February 19 at 1:14 PM |
 | DelMar Pharma up 4% advancement of VAL-083 study
seekingalpha.com - February 19 at 1:14 PM |
| DelMar Pharmaceuticals [Nasdaq:DMPI] Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 For First-Line Treatment of Brain Tumors
finance.yahoo.com - February 19 at 8:13 AM |
| DelMar Pharmaceuticals Announces Fiscal Second Quarter 2020 Financial Results and Recent Corporate Updates
finance.yahoo.com - February 13 at 8:30 AM |
| Will DelMar Pharmaceuticals (NASDAQ:DMPI) Spend Its Cash Wisely?
finance.yahoo.com - February 10 at 1:54 PM |
| DelMar Pharma up 16% premarket on positive VAL-083 data
seekingalpha.com - January 29 at 2:19 PM |
| DelMar Pharmaceuticals Announces Peer-Reviewed Publication of Interim Results of Phase 2 Clinical Trial of VAL-083 As First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma Multiforme
finance.yahoo.com - January 29 at 8:05 AM |
| DelMar Pharmaceuticals to Present at the LD Micro 12th Annual Main Event on December 10, 2019
finance.yahoo.com - December 3 at 12:46 PM |
| /C O R R E C T I O N -- DelMar Pharmaceuticals, Inc./
finance.yahoo.com - November 25 at 2:14 PM |
| DelMar Pharmaceuticals Announces Fiscal First Quarter 2020 Financial Results and Recent Corporate Updates
finance.yahoo.com - November 14 at 8:19 AM |
| Before You Buy DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI), Consider Its Volatility
finance.yahoo.com - November 11 at 2:13 PM |
| DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
finance.yahoo.com - November 5 at 12:35 PM |
| DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2019 Society for NeuroOncology Annual Meeting
finance.yahoo.com - October 29 at 1:28 PM |
| DelMar Pharmaceuticals to Present on October 29th at the 5th Annual Dawson James Small Cap Growth Conference
finance.yahoo.com - October 24 at 12:41 PM |
| DelMar Pharmaceuticals (DMPI) Presents At MicroCap Rodeo Investor Conference - Slideshow
seekingalpha.com - October 17 at 5:57 PM |
| DelMar Pharmaceuticals to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 11:30 AM Central Time
finance.yahoo.com - October 10 at 9:08 AM |
| DelMar Pharmaceuticals to Present at the Fall Investor Summit on September 16, 2019
finance.yahoo.com - September 12 at 1:20 PM |
| DelMar Pharmaceuticals Announces Fiscal Year 2019 Financial Results and Recent Corporate Updates
finance.yahoo.com - September 11 at 5:56 AM |
| DelMar regains Nasdaq listing compliance
seekingalpha.com - September 9 at 12:57 PM |
| DelMar Pharmaceuticals Reports Full Compliance with Nasdaq Listing Criteria
finance.yahoo.com - September 9 at 12:56 PM |
| DelMar Pharmaceuticals Relocates Headquarters to San Diego, California
finance.yahoo.com - September 4 at 8:46 AM |
| 12 Healthcare Stocks Moving In Tuesday's Pre-Market Session
www.msn.com - August 27 at 10:19 PM |
| DelMar Pharma down 12% after trial update
seekingalpha.com - August 27 at 10:19 PM |
| DelMar Pharma down 35% premarket ahead of equity offering pricing
seekingalpha.com - August 14 at 11:13 PM |
| DelMar Pharmaceuticals Announces Pricing Of $6.8 Million Underwritten Public Offering
finance.yahoo.com - August 14 at 11:13 PM |
| DelMar Pharma up 5% on positive VAL-083 data
seekingalpha.com - August 14 at 12:17 AM |
| DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
finance.yahoo.com - August 14 at 12:16 AM |
| DelMar Pharma to offer nearly 5M shares
seekingalpha.com - August 13 at 5:56 AM |
| DelMar Pharma up 43% on advancement of VAL-083
seekingalpha.com - August 1 at 12:37 AM |
| DelMar Pharmaceuticals Achieves Two-Thirds Enrollment for Phase 2 Clinical Trial of VAL-083 As First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
finance.yahoo.com - July 31 at 8:15 AM |
| DelMar Pharmaceuticals Enrolls First Patient in the Recently-Approved Adjuvant Setting Arm of Phase 2 Study of VAL-083 for the Treatment of MGMT-Unmethylated Glioblastoma Multiforme
finance.yahoo.com - July 25 at 12:14 AM |
| Here Is What's Driving The Rally In DelMar Pharmaceuticals
finance.yahoo.com - July 25 at 12:14 AM |
| DelMar Announces Relocation of Company Headquarters to San Diego
finance.yahoo.com - July 22 at 8:10 PM |
| DelMar to relocate headquarters to San Diego
seekingalpha.com - July 10 at 7:14 PM |
| Delmar Pharmaceuticals terminates rights offering
seekingalpha.com - June 27 at 8:04 AM |
| DelMar Pharma extends rights offering to July 12
seekingalpha.com - June 26 at 8:03 AM |
| DelMar Pharmaceuticals Announces Closing of Financing
finance.yahoo.com - June 21 at 8:01 PM |
| Delmar Pharmaceuticals Updates The Terms Of Previously Announced Rights Offering
finance.yahoo.com - June 21 at 8:01 PM |
| Delmar Pharma updates terms of rights offering
seekingalpha.com - June 11 at 8:04 AM |
